{"entity":{"id":"nct05103358","kind":"trial","name":"Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)","aka":[],"tldr":"A phase 2 trial of Sirolimus protein-bound particles in metastatic cancer, run by Aadi Bioscience, Inc., active and no longer recruiting.","summary":"Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) is a phase 2 interventional study registered as NCT05103358 by Aadi Bioscience, Inc., with 120 participants planned, started 2022-02-15 and due to reach its primary completion in 2024-12-31. Interventions recorded: nab-sirolimus. Conditions listed: Tumor, Tumor, Solid, Metastasis, Metastatic Cancer. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05103358","url":"https://clinicaltrials.gov/study/NCT05103358"}],"tags":["ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["sirolimus-albumin-bound"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT05103358","phase":"2","setting":"A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes.","sponsor":"Aadi Bioscience, Inc.","enrolled":120,"outcomes":[]},"route":"/trials/nct05103358/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"sirolimus-albumin-bound","kind":"drug","name":"Sirolimus protein-bound particles","route":"/drugs/sirolimus-albumin-bound/"}]}}